List view / Grid view
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
For the treatment of pancreatic cancer, EryTech are now looking to develop 'tumour starvation' treatments for acute leukaemia and have enrolled their...
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The primary endpoint of the trial being the percentage of patients who achieved a sustained virologic response 12 weeks after treatment (SVR12)...
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug is the first treatment to target hypophosphatasia, a condition affecting the development of bone, and could allow children to lead a normal life...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The expanded use is for Ilaris, a selective, high-affinity, human monoclonal antibody that inhibits Interleukin-1 (IL-1) beta, part of the immune system...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Until now, the time-consuming marketing authorisation process was the only path to being able to market products containing St John’s Wort and Valerian...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
In July, Sanofi revealed the development agreement with the Walter Reed Army Institute of Research on the co-development of a Zika vaccine candidate...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Also known as "Butterfly skin" syndrome, epidermolysis bullosa (EB) is a rare genetic skin disease that is caused by the absence of a gene (COL7A1)...
26 September 2016 | By Edinburgh Instruments
Researchers at North Carolina State University, led by Prof. Felix Castellano, have shown for the first time that the photogenerated triplet exciton in semiconductor nanocrystals can be harvested by surface bound molecular acceptors, exhibited by a six-order magnitude increase in the lifetime of the originally prepared excited state...
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories is pleased to introduce stability storage and testing as its latest service offering...
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide...
23 September 2016 | By BBI Solutions
BBI Solutions has launched Morffi™, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September...
23 September 2016 | By CI Precision
Global consumer goods group RB (formerly known as Reckitt Benckiser) is implementing CI Precision’s MES solution (Ci-DMS) in the dispensing area at their manufacturing plant in Pakistan...
21 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Fewer serious adverse events were seen with semaglutide vs placebo; however, treatment discontinuation due to adverse events was more frequent...
21 September 2016 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners is pleased to announce a number of new appointments in the US and in London...
21 September 2016 | By Niamh Louise Marriott, Digital Content Producer
T-Guard has been shown to be well tolerated, with a manageable side effect profile and no severe infusion reactions in patients with acute GVHD...
